• Regulatory NewsRegulatory News

    Sanders, Cummings Slam Marathon’s $89,000 Price Tag for Old Steroid

    Sen. Bernie Sanders (D-VT) and Rep. Elijah Cummings (D-MD) on Monday wrote to Illinois-based Marathon Pharmaceuticals CEO Jeffrey Aronin, calling the company’s plan to charge $89,000 annually for its recently approved treatment “outrageous.” Not only did Marathon not develop the steroid, known as Emflaza (Deflazacort) and approved by the US Food and Drug Administration last week to treat Duchenne Muscular Dystrophy, but the letter notes that the steroid is curren...
  • Regulatory NewsRegulatory News

    Anabolic Steroid Regulation Bill Awaits President's Signature

    New legislation set to be signed into law by US President Barack Obama would ban dozens of active ingredients now used in the production of anabolic steroids, and also make it easier for federal authorities to prohibit the production of similar products. Background The legislation, the Designer Anabolic Steroid Control Act (DASCA) of 2014, was passed by the US House of Representatives on 15 September 2014, and the US Senate on 11 December 2014. According to its spo...
  • Legislators, Regulators to Enhance Regulation of Anabolic Steroids

    • 01 August 2012
    Legislators and regulatory officials at the Drug Enforcement Administration (DEA) are both proposing to subject anabolic steroids to more stringent controls under the Controlled Substances Act (CSA) , according to documents filed in the Federal Register and at the Government Printing Office. DEA on 30 July released a final regulation classifying two additional anabolic steroids as Schedule II drugs under the CSA : prostanozol and methasterone. Under the definit...